Articles: low-back-pain.
-
Advances in therapy · Oct 2008
Clinical TrialOpen experience with a new myorelaxant agent for low back pain.
Eperisone hydrochloride has been recently proposed as a muscle relaxant for the treatment of muscle contracture and chronic low back pain (LBP) as it is devoid of clinically relevant sedative effects on the central nervous system (CNS). We tested this hypothesis by performing a study of patients with LBP and muscle contracture who were treated with full-dose eperisone. ⋯ Eperisone had an analgesic and muscle relaxant effect in patients with LBP. It should be noted that while it is common practice in rheumatology to combine a pain killer with a muscle relaxant in order to achieve a satisfactory result on both symptoms, the present results with eperisone were achieved with a single drug. With an improved tolerability profile compared with nonsteroidal anti-inflammatory drugs, and a lack of significant adverse effects on the CNS, eperisone hydrochloride represents a valuable alternative to traditional analgesics and muscle relaxants for the treatment of LBP.
-
Subchondral signal abnormalities have been suggested to play an important role in chronic low back pain (LBP) syndromes. Their natural course is not well known. In this study the morphology and natural course of isolated subchondral signal abnormalities in the lumbosacral spine were analyzed with MRI. ⋯ They seem to have a highly variable course. There appears to be a link between endplate lesions and subchondral signal abnormalities. Further study is needed to explain the contribution of these findings to low back symptoms.
-
Introduction. Spinal cord stimulation is a widely used treatment modality for chronic pain, especially failed back surgery syndrome. However, migration of the lead or leads, coverage of axial pain, and the selection of an optimal system configuration continue to be subjects for serious debate. Materials and Methods. A retrospective study of the use of the method of "midline anchoring" of a single Octrode® lead, in 54 patients with low back and/or lower extremity pain, was done to assess the efficacy of this technique. ⋯ A "guarded cathode" array was used in the vast majority of the cases, with a relatively low position of the lead. Conclusions. "Midline anchoring" of the spinal cord stimulation lead is an effective implantation technique, allowing the use of a single, percutaneous, Octrode® lead, while preventing lead migration and allowing capture of axial and lower extremity pain, unilateral as well as bilateral. This study revives the idea of a single lead as a possible optimal configuration.
-
To determine if asymmetry of trunk muscles and deficits of motor control exist among elite cricketers with and without low back pain (LBP). ⋯ This study provides new insights into trunk muscle size and function in elite cricketers, and evidence of impaired motor control in elite cricketers with LBP. Rehabilitation using a motor control approach has been shown to be effective for subjects with LBP, and this may also benefit elite cricketers.
-
Comparative Study
Physiotherapy for low back pain: differences between public and private healthcare sectors in Ireland--a retrospective survey.
European clinical guidelines for low back pain (LBP) recommend early referral of appropriate patients to health services such as physiotherapy. The current study aimed to investigate any differences between the physiotherapy management of LBP, and the physiotherapist and patient profiles in public and private health settings in Ireland. ⋯ Findings showed longer waiting times, and a higher number and duration of physiotherapy treatments for acute and chronic LBP in the public setting suggesting the need to develop publicly funded primary healthcare in Ireland.